A Multicenter Study Assessing the Efficacy and Safety of STN1010904 Ophthalmic Suspension 0.03% and 0.1% Compared With Vehicle in Subjects With Fuchs Endothelial Corneal Dystrophy (FECD)
Clinical trial NCT05376176 · COMPLETED
Trial details
- NCT number
- NCT05376176
- Sponsor
- Santen Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-19
- Primary completion
- 2025-05-26
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.